QOF database

Home | News | Downloads
HOLME-BUBWITH MEDICAL GROUP

HOLME-BUBWITH MEDICAL GROUP

THE SURGERY, RUSH VIEW, HOLME-ON-SPALDING MOOR, YORK

HF 4

The percentage of patients with a current diagnosis of heart failure due to LVD who are currently treated with an ACE inhibitor or Angiotensin Receptor Blocker, who are additionally treated with a beta-blocker licensed for heart failure, or recorded as intolerant to or having a contraindication to beta-blockers.

IndicatorYearNumeratorDenominatorRatioCentile
HF 4 2010 9 10 90.0%
HF 4 2011 8 9 88.9%
HF 4 2012 13 15 86.7%
HF 4 2013 15 15 100.0%
HF004 2014 6 8 75.0%
HF004 2015 5 6 83.3%